Diferencia entre revisiones de «Atorvastatin»
(Created page with "==Administration== *Type: Statins (HMG-CoA Reductase Inhibitor) *Dosage Forms: *Routes of Administration: PO *Common Trade Names: Lipitor ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== ===Pregnancy Rating=== * ===Lactation risk=== * ===Renal Dosing=== *Adult: *Pediatric: ===Hepatic Dosing=== *Adult: *Pediatric: ==Contraindications== *Allergy to class/drug ==Adverse Reactions== ===Serious=== ===Common=== ==Pharma...") |
|||
| Línea 6: | Línea 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Hyperlipidemia=== | |||
*Moderate Intensity: 10-20 mg PO daily | |||
*High Intensity: 40-80 mg PO daily | |||
===Acute Coronary Syndrome=== | |||
*80 mg PO (Single dose prior to PCI) | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revisión del 15:41 20 ago 2023
Administration
- Type: Statins (HMG-CoA Reductase Inhibitor)
- Dosage Forms:
- Routes of Administration: PO
- Common Trade Names: Lipitor
Adult Dosing
Hyperlipidemia
- Moderate Intensity: 10-20 mg PO daily
- High Intensity: 40-80 mg PO daily
Acute Coronary Syndrome
- 80 mg PO (Single dose prior to PCI)
Pediatric Dosing
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: